Novel Approaches in Cardiovascular Diagnostics: Mapping the Research Landscape of the 21st Century

Carlos Morgado Areia; Michael Taylor; Haipeng Liu

doi:10.1201/9781003481621-1

Novel Approaches in Cardiovascular Diagnostics: Mapping the Research Landscape of the 21st Century

Carlos Morgado Areia
, Michael Taylor
, Haipeng Liu

Oxford Brookes University
University of Wolverhampton

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

This chapter provides a comprehensive scientometric analysis of novel approaches in cardiovascular diagnostics from 2000 to 2024. The study leverages advanced bibliometric tools to examine the evolution of key technologies, including artificial intelligence (AI), computational fluid dynamics, data fusion, genetic biomarkers, imaging technologies, nanodiagnosis, and wearables. Bespoke datasets are created using Dimensions and Altmetric data, as well Google Cloud products, to analyse publication trends, clinical trials, patent activity, and policy citations, amongst others. Key findings highlight the dominance of imaging technologies’ research volume, reflecting their central role in cardiovascular diagnostics. AI and genetic biomarkers are rapidly growing fields, enhancing diagnostic precision and personalised care. Emerging technologies like wearables and nanodiagnosis show promise for continuous monitoring and early detection. The chapter also explores the impact of COVID-19 on accelerating research, the shift towards AI and data-driven diagnostics, and the global contributions to cardiovascular research. The analysis of patent and policy citations underscores the real-world impact of these technologies, with imaging and genetic biomarkers leading in policy/clinical guidelines integration.

Original language	English
Title of host publication	Cutting-Edge Diagnostic Technologies in Cardiovascular Diseases
Subtitle of host publication	Towards Data-Driven Smart Healthcare
Editors	Haipeng Liu, Gary Tse
Publisher	CRC Press, Taylor & Francis Group
Chapter	1
Pages	1-27
Number of pages	27
ISBN (Electronic)	9781003481621
ISBN (Print)	9781032771694
DOIs	https://doi.org/10.1201/9781003481621-1
Publication status	Published - 23 Jun 2025

Bibliographical note

Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Scientometric analysis
cardiovascular disease,
genetic biomarkers
nanodiagnosis,
wearables.

Access to Document

10.1201/9781003481621-1

Cite this

Novel Approaches in Cardiovascular Diagnostics: Mapping the Research Landscape of the 21st Century. / Morgado Areia, Carlos; Taylor, Michael; Liu, Haipeng.
Cutting-Edge Diagnostic Technologies in Cardiovascular Diseases: Towards Data-Driven Smart Healthcare. ed. / Haipeng Liu; Gary Tse. CRC Press, Taylor & Francis Group, 2025. p. 1-27.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

@inbook{f05df07cef144457b20a50dd578d0667,

title = "Novel Approaches in Cardiovascular Diagnostics: Mapping the Research Landscape of the 21st Century",

abstract = "This chapter provides a comprehensive scientometric analysis of novel approaches in cardiovascular diagnostics from 2000 to 2024. The study leverages advanced bibliometric tools to examine the evolution of key technologies, including artificial intelligence (AI), computational fluid dynamics, data fusion, genetic biomarkers, imaging technologies, nanodiagnosis, and wearables. Bespoke datasets are created using Dimensions and Altmetric data, as well Google Cloud products, to analyse publication trends, clinical trials, patent activity, and policy citations, amongst others. Key findings highlight the dominance of imaging technologies{\textquoteright} research volume, reflecting their central role in cardiovascular diagnostics. AI and genetic biomarkers are rapidly growing fields, enhancing diagnostic precision and personalised care. Emerging technologies like wearables and nanodiagnosis show promise for continuous monitoring and early detection. The chapter also explores the impact of COVID-19 on accelerating research, the shift towards AI and data-driven diagnostics, and the global contributions to cardiovascular research. The analysis of patent and policy citations underscores the real-world impact of these technologies, with imaging and genetic biomarkers leading in policy/clinical guidelines integration.",

keywords = "Scientometric analysis, cardiovascular disease,, genetic biomarkers, nanodiagnosis,, wearables.",

author = "\{Morgado Areia\}, Carlos and Michael Taylor and Haipeng Liu",

note = "Copyright {\textcopyright} and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders. ",

year = "2025",

month = jun,

day = "23",

doi = "10.1201/9781003481621-1",

language = "English",

isbn = "9781032771694",

pages = "1--27",

editor = "Haipeng Liu and Gary Tse",

booktitle = "Cutting-Edge Diagnostic Technologies in Cardiovascular Diseases",

publisher = "CRC Press, Taylor \& Francis Group",

address = "United States",

}

TY - CHAP

T1 - Novel Approaches in Cardiovascular Diagnostics

T2 - Mapping the Research Landscape of the 21st Century

AU - Morgado Areia, Carlos

AU - Taylor, Michael

AU - Liu, Haipeng

N1 - Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

PY - 2025/6/23

Y1 - 2025/6/23

N2 - This chapter provides a comprehensive scientometric analysis of novel approaches in cardiovascular diagnostics from 2000 to 2024. The study leverages advanced bibliometric tools to examine the evolution of key technologies, including artificial intelligence (AI), computational fluid dynamics, data fusion, genetic biomarkers, imaging technologies, nanodiagnosis, and wearables. Bespoke datasets are created using Dimensions and Altmetric data, as well Google Cloud products, to analyse publication trends, clinical trials, patent activity, and policy citations, amongst others. Key findings highlight the dominance of imaging technologies’ research volume, reflecting their central role in cardiovascular diagnostics. AI and genetic biomarkers are rapidly growing fields, enhancing diagnostic precision and personalised care. Emerging technologies like wearables and nanodiagnosis show promise for continuous monitoring and early detection. The chapter also explores the impact of COVID-19 on accelerating research, the shift towards AI and data-driven diagnostics, and the global contributions to cardiovascular research. The analysis of patent and policy citations underscores the real-world impact of these technologies, with imaging and genetic biomarkers leading in policy/clinical guidelines integration.

AB - This chapter provides a comprehensive scientometric analysis of novel approaches in cardiovascular diagnostics from 2000 to 2024. The study leverages advanced bibliometric tools to examine the evolution of key technologies, including artificial intelligence (AI), computational fluid dynamics, data fusion, genetic biomarkers, imaging technologies, nanodiagnosis, and wearables. Bespoke datasets are created using Dimensions and Altmetric data, as well Google Cloud products, to analyse publication trends, clinical trials, patent activity, and policy citations, amongst others. Key findings highlight the dominance of imaging technologies’ research volume, reflecting their central role in cardiovascular diagnostics. AI and genetic biomarkers are rapidly growing fields, enhancing diagnostic precision and personalised care. Emerging technologies like wearables and nanodiagnosis show promise for continuous monitoring and early detection. The chapter also explores the impact of COVID-19 on accelerating research, the shift towards AI and data-driven diagnostics, and the global contributions to cardiovascular research. The analysis of patent and policy citations underscores the real-world impact of these technologies, with imaging and genetic biomarkers leading in policy/clinical guidelines integration.

KW - Scientometric analysis

KW - cardiovascular disease,

KW - genetic biomarkers

KW - nanodiagnosis,

KW - wearables.

UR - https://www.scopus.com/pages/publications/105008160748

U2 - 10.1201/9781003481621-1

DO - 10.1201/9781003481621-1

M3 - Chapter

SN - 9781032771694

SP - 1

EP - 27

BT - Cutting-Edge Diagnostic Technologies in Cardiovascular Diseases

A2 - Liu, Haipeng

A2 - Tse, Gary

PB - CRC Press, Taylor & Francis Group

ER -

Novel Approaches in Cardiovascular Diagnostics: Mapping the Research Landscape of the 21st Century

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Embargoed Document

Fingerprint

Cite this